Skip to main content
Premium Trial:

Request an Annual Quote

DiaGenic Taps Ferrer InCode as Distributor

NEW YORK (GenomeWeb News) – Norwegian gene expression-based diagnostics company DiaGenic said today that it has signed up Ferrer InCode to distribute its Alzheimer's disease test in certain countries in Europe and Latin America.

Barcelona, Spain-based Ferrer InCode will distribute the ADtect test for early diagnosis of Alzheimer's disease in Germany, Belgium, France, the Netherlands, Italy, Spain, and Portugal, as well as in Latin American nations.

A subsidiary of Grupo Ferrer International, Ferrer InCode is focused on offering personalized medicine products including prognostic and predictive technologies based on genomics, proteomics, metabolomics, and bioinformatics.

"Early detection enables subsequent early initiation of active management strategies, which may preserve the patients' level of function for longer and increases the chances of delaying the progression of the disease," DiaGenic CEO Erik Christensen said in a statement.

"Current evidence suggests that pharmacological treatments and caregiver interventions can delay entry into nursing homes, thus reducing healthcare costs," Christensen added. "However, these cost savings are not being realized because many patients with Alzheimer's disease are either not diagnosed or diagnosed at a late stage of the disease."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.